Hanjo Kim

Hanjo Kim is a distinguished researcher with extensive experience in the pharmaceutical sector, having held senior leadership positions at Standigm, where he directed global strategy and medicinal chemistry efforts, leveraging AI to enhance drug discovery processes. He earned his Ph.D. in Organic Chemistry from Yonsei University, where his research centered on the synthesis and analysis of artemisinin derivatives. Hanjo's career also includes significant roles in R&D at CJ Healthcare (now HK innoN), where he pioneered molecular modeling systems and innovative drug discovery methodologies. Active in the scientific community, he contributes to numerous publications and media discussions on advancements in chemistry and drug discovery technologies. His expertise spans drug discovery projects, cheminformatics, and AI/ML, making him a key figure at the intersection of chemistry and technology in the modern pharmaceutical sector.